Halozyme Therapeutics Inc (NASDAQ:HALO)

18.98
Delayed Data
As of Dec 13
 +0.26 / +1.39%
Today’s Change
13.24
Today|||52-Week Range
19.73
+29.73%
Year-to-Date
No recent news for Halozyme Therapeutics Inc.

Today’s Trading

Previous close18.72
Today’s open18.71
Day’s range18.48 - 19.07
Volume1,256,058
Average volume (3 months)1,341,212
Market cap$2.8B
Data as of 4:00pm ET, 12/13/2019

Growth & Valuation

Earnings growth (last year)-221.61%
Earnings growth (this year)+26.20%
Earnings growth (next 5 years)+55.00%
Revenue growth (last year)-52.04%
P/E ratioNM
Price/Sales13.83
Price/Book11.04

Competitors

 Today’s
change
Today’s
% change
KODKodiak Sciences Inc+0.56+0.89%
BOLDAudentes Therapeutic...+0.03+0.05%
EBSEmergent BioSolution...-2.06-3.81%
XLRNAcceleron Pharma Inc+0.54+1.08%
Data as of 6:30pm ET, 12/13/2019

Financials

Next reporting dateFebruary 26, 2020
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$151.9M
Annual profit (last year)-$80.3M
Net profit margin-52.90%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
--, --

Forecasts